Blake Charles A, Barker Kenneth L, Sobel Burton E
Department of Cell and Developmental Biology and Anatomy, University of South Carolina, School of Medicine, Columbia, SC 29208, USA.
Exp Biol Med (Maywood). 2006 Dec;231(11):1680-1. doi: 10.1177/153537020623101102.
This symposium addresses careers in drug development in industry; the performance of translational research by academia, industry, and both; and numerous factors pertinent to alliances essential to drug discovery and development. Drug development is a complex process that regularly involves effective collaborations between academic and physician scientists and industry. There are specific occupational factors affecting recruitment of scientists and physicians in drug development programs in industry; ideal backgrounds for successful applicants for positions in industry in drug development; ethical and regulatory considerations particularly germane to the performance of scientists and physicians in drug development programs in industry and at universities; and particular gratifications available to scientists in industry working on drug development. Both similarities and differences characterize the performance of translational research in industry compared with academia. In industry, logistic, operational, and scientific oversight is complex, especially because it often involves relationships with clinical enterprises outside of the corporation. The process is long and arduous from formulation of a good idea in discovery to acceptance of a novel drug in the marketplace. Collaborations and partnerships by industry often involving academia and confrontation of multiple issues are pivotal.
本次研讨会探讨了制药行业的药物研发职业;学术界、行业以及双方开展的转化研究的情况;以及对药物发现与开发至关重要的联盟相关的诸多因素。药物研发是一个复杂的过程,通常需要学术科学家、医师科学家与行业之间进行有效的合作。在制药行业的药物研发项目中,存在一些影响科学家和医师招聘的特定职业因素;制药行业职位成功申请者的理想背景;与制药行业和大学的药物研发项目中科学家和医师的工作表现特别相关的伦理和监管考量;以及从事药物研发的行业科学家所能获得的特殊满足感。与学术界相比,行业内转化研究的表现既有相似之处,也有不同之处。在行业内,后勤、运营和科学监督都很复杂,特别是因为这通常涉及与公司外部临床企业的关系。从发现阶段形成一个好想法到新药在市场上被接受,这个过程漫长而艰巨。行业内的合作与伙伴关系(通常涉及学术界)以及对多个问题的应对是关键。